Kechuang Bio's brain-computer interface technology is leading in several aspects. First, it has a high recognition rate; second, it has a wide recognition range; and third, it requires fewer electrode points.
Products like those released by Musk's company Neuralink require the implantation of more than three thousand electrodes in the brain to detect neuronal activity.
Kechuang Bio does not require implanted electrodes, and only requires about one hundred electrodes. Its recognition success rate is also far superior to that of its competitors. This difference is the difference between laboratory products and commercially viable products.
In the field of biomedicine, the gap between Zheng Li and Lanxing Biomedical is even greater than the gap between a Nobel Prize winner in Biology and a high school student.
The key to the brain-computer interface that Zheng Li pulled out lies in solving the problem of how to filter out unnecessary neuronal signals from the brain when there are too many neuronal signals, leaving only the neural signals that I need to identify.
Ren Yong was not discouraged by Cheng Gang's rejection. His main purpose in coming was to express his gratitude and his hope to maintain a long-term cooperative relationship with Kechuang Biotechnology.
Regarding the hope that Kechuang Biotechnology will refuse to grant licenses to Samsung and Apple, that would be ideal if it were possible, but it's okay if it's not.
Because if he were in the same company as Kechuang Biotechnology, he wouldn't do that either.
He only regrets not having invested in the Series A round of funding for Kechuang Bio.
In China's venture capital circles, Lei Jun's acquisition of a 10% stake in Kechuang Biotechnology for 50 million yuan is considered a legend. People say Lei Jun is incredibly lucky, as his 50 million yuan investment has multiplied a thousandfold in less than two years.
The success of Kechuang Bio has also made it easy for some biopharmaceutical companies with core technologies to obtain large investments in recent years. For example, after failing to participate in Kechuang Bio's second round of investment, CMB International invested in five other biopharmaceutical companies.
One of the biopharmaceutical companies claimed to be developing an industrially synthesized endorphin route that differed from that of Kechuang Bio.
Ren Yong: "I can fully understand your company's decision. In the future, Huawei hopes to cooperate deeply with your company in the field of brain-computer interface. Brain-computer interface can not only be applied to the personal end, but also to Industry 4.0."
After its mobile phone business stagnated and even saw its market share continue to decline due to the blockade, Hua Wei pinned its hopes on smart industry as its next profit growth point.
Cheng Gang nodded and said, "I will report this to Chairman Zheng."
Cheng Gang knew he wasn't part of Zheng Li's inner circle, so he was very cautious in his position as general manager of Kechuang Biotechnology, reporting any important matters to Zheng Li.
Ren Yong continued, "When will Chairman Zheng return to Suzhou? Before I came, President Yu expressed his hope to have a face-to-face talk with Chairman Zheng."
Cheng Gang replied, "Chairman Zheng will not be returning to China in the near future. Firstly, due to the impact of the epidemic, returning to China would require at least a 14-day quarantine period. Chairman Zheng is a workaholic, and he might go crazy if he were to be quarantined in a hotel for 14 days."
"In addition, the brain-computer interface technology currently developed by Kechuang Biotechnology is most effective for people of East Asian descent who speak Chinese."
"Chairman Zheng is currently conducting research and development on brain-computer interfaces for other mainstream language systems."
An article speculating on the influence of language families on brain neural signals was published in the latest issue of Nature.
Although Zheng Li's conjecture lacks sufficient experimental data to support it, he is now a top expert in the field of brain-computer interfaces, and his conjecture can be published.
In California, America, thousands of miles away from Suzhou, Neuralink has obtained test products from Kechuang Bio through Apple.
After they reported the test data to Musk, Musk, known as Iron Man, flew into a rage:
“Back in 2018 you told me that we would operate iPhones through brain-computer interfaces. Three years have passed, and our lab products are still incomplete.”
Neuralink, Elon Musk's brain-computer interface company, announced in a speech at the California Academy of Sciences on July 17, 2019, that it plans to develop technology that allows people to control iPhones directly with their brains.
"The accuracy rate of our brain-computer interface products on mobile devices is less than 50%."
"The innovative biotechnology from China has been implemented. What you see in front of you is their brain-computer interface technology!"
"Chinese people can achieve a 99% recognition accuracy rate using this technology, and they don't need to have those damn electrodes implanted in their brains!"
"Your idea is to develop a damn CPU and connect it to the brain through a wire thinner than a human hair."
“What’s even more ridiculous is that these sensors are installed on the surface of the skull, and then how can the information be transmitted to the wearable computer ‘Link’ located behind the ear?”
"When you see the technology of Kechuang Biotechnology, don't you feel ashamed?"
"Your proposed solutions are so outdated and ridiculous, and more importantly, you haven't even implemented such outdated technology yet!"
Neuralink plans to use this method, allowing the brain to connect to an iPhone via an app.
"Chinese companies can simply wear headphones and control iPhones with their thoughts. What about us? We have to implant those damn sensors into the surface of the skull."
"Don't you guys think this is so cyberpunk! So cool! Those dama addicts would not hesitate to cut open their heads and implant our electrode sensors in them!"
Musk couldn't contain his anger because he had thought his company, Neuralink, was at the forefront of brain-computer interfaces.
My dear reader, there's more to this chapter! Please click the next page to continue reading—even more exciting content awaits!
Continue read on readnovelmtl.com
